Prices of battery materials lithium and cobalt assessed by consultancy Benchmark Minerals Intelligence (BMI) will be used for contracts launched by Intercontinental Exchange (ICE) in June, BMI told Reuters. For BMI, a price reporting agency (PRA), this is an important step in having its prices used to settle derivative contracts traded on exchanges, an area dominated by information firms Fastmarkets and S&P Global Commodity Insights. An agreement between BMI and ICE signed earlier this year covers prices of lithium carbonate, lithium hydroxide, spodumene concentrate and cobalt hydroxide, BMI said.
Best money market account rates today, April 23, 2025 (Secure up to 4.41% APY)
Looking for the best money market account interest rates available today? Here’s a look at where to find the highest rates and whether now is a good time to open a money market account.
Big investors increase their allocations to crypto
Buoyed by the Trump Administration’s support for cryptocurrencies, 83% of international investors say they’ll put more cash into them this year.
Wall Street ends higher on hopes of trade war de-escalation
NEW YORK (Reuters) -Wall Street stocks advanced on Wednesday on revived hopes for progress in the U.S.-China trade dispute and as President Donald Trump soothed fears the Federal Reserve could lose its autonomy with reassurances that he has "no intention of firing" Fed Chair Jerome Powell. All three major U.S. stock indexes pared gains by the closing bell. "We had such a strong open, it was really related to developments out of Washington," said Russell Price, chief economist at Ameriprise in Troy, Michigan.
CEO gloom rivals financial crisis as tariffs hit S&P 500 stocks
(Bloomberg) -- Not since the financial crisis has Corporate America been so downbeat about the state of the economy in earnings calls, an ominous sign for investors trying to figure out how much more pain Donald Trump’s trade war will inflict on the stock market.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeDOGE Visits National Gallery of Art to Discuss Museum’s Legal StatusThe Racial Wealth Gap Is Not Just About MoneyBackyard Micro-Flats Aim to Ease South A
3 Reasons RUN is Risky and 1 Stock to Buy Instead
Sunrun’s stock price has taken a beating over the past six months, shedding 50.7% of its value and falling to $6.83 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Sell BRC and 1 Stock to Buy Instead
Brady trades at $68.82 per share and has stayed right on track with the overall market, losing 6% over the last six months while the S&P 500 is down 6.9%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons CGNX is Risky and 1 Stock to Buy Instead
Cognex has gotten torched over the last six months - since October 2024, its stock price has dropped 35.6% to $24.96 per share. This may have investors wondering how to approach the situation.
3 Reasons to Avoid CCOI and 1 Stock to Buy Instead
Cogent’s stock price has taken a beating over the past six months, shedding 36.5% of its value and falling to $52.28 per share. This might have investors contemplating their next move.
3 Reasons to Sell GDRX and 1 Stock to Buy Instead
GoodRx’s stock price has taken a beating over the past six months, shedding 30.4% of its value and falling to $4.55 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.